DENOSUMAB PERSISTENCE IN POSTMENOPAUSAL AND MALE OSTEOPOROSIS IN ROUTINE CLINICAL PRACTICE IN HUNGARY: A NATIONAL, SINGLE-ARM, PROSPECTIVE OBSERVATIONAL STUDY

被引：0
|
作者：
Gaal, J. [1 ]
Valkusz, Z. [2 ]
Kudlak, K. [3 ]
Balogh, I. [4 ]
Molnar, E. [5 ]
Takacs, I. [6 ]
机构：
[1] Univ Debrecen, Dept Rheumatol, Kenezy Gyula Campus, Debrecen, Hungary
[2] Univ Szeged, Fac Med, Dept Med 1, Albert Szent Gyorgyi Clin Ctr, Szeged, Hungary
[3] Univ Pecs, Teaching Hosp Mor Kaposi, Dept Osteoporosis & Gen Rheumatol 3, Kaposvar, Hungary
[4] St Rafael Hosp Zala Cty, Dept Rheumatol 2, Zalaegerszeg, Hungary
[5] Amgen Kft, Budapest, Hungary
[6] Semmelweis Univ, Dept Internal Med & Oncol, Budapest, Hungary
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2023年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P122
引用
收藏
页码：S134 / S135
页数：2
相关论文
共 50 条
  • [1] PERSISTENCE TO DENOSUMAB IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AT INCREASED FRACTURE RISK TREATED IN ROUTINE CLINICAL PRACTICE IN BULGARIA
    Monov, S.
    Nestorova, R.
    Velkova, M.
    Temelkova, N.
    Jeleva, S.
    Petkova, R.
    Petranova, T.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S442 - S443
  • [2] Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
    Silverman, S. L.
    Siris, E.
    Kendler, D. L.
    Belazi, D.
    Brown, J. P.
    Gold, D. T.
    Lewiecki, E. M.
    Papaioannou, A.
    Simonelli, C.
    Ferreira, I.
    Balasubramanian, A.
    Dakin, P.
    Ho, P.
    Siddhanti, S.
    Stolshek, B.
    Recknor, C.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (01) : 361 - 372
  • [3] Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
    S. L. Silverman
    E. Siris
    D. L. Kendler
    D. Belazi
    J. P. Brown
    D. T. Gold
    E. M. Lewiecki
    A. Papaioannou
    C. Simonelli
    I. Ferreira
    A. Balasubramanian
    P. Dakin
    P. Ho
    S. Siddhanti
    B. Stolshek
    C. Recknor
    Osteoporosis International, 2015, 26 : 361 - 372
  • [4] EVALUATION OF DENOSUMAB PERSISTENCE IN POSTMENOPAUSAL WOMEN AFFECTED BY SEVERE OSTEOPOROSIS: A MULTICENTER OBSERVATIONAL REAL PRACTICE STUDY
    Migliaccio, S.
    Francomano, D.
    Romagnoli, E.
    Marocco, C.
    Fornari, R.
    Resmini, G.
    Buffa, A.
    Di Pietro, G.
    Corvaglia, S.
    Gimigliano, F.
    Moretti, A.
    de Sire, A.
    Malavolta, N.
    Lenzi, A.
    Greco, E. A.
    Iolascon, G.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S442 - S442
  • [5] Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study
    Adami, Giovanni
    Pedrollo, Elisa
    Rossini, Maurizio
    Fassio, Angelo
    Braga, Vania
    Pasetto, Emma
    Pollastri, Francesco
    Benini, Camilla
    Viapiana, Ombretta
    Gatti, Davide
    JBMR PLUS, 2024, 8 (04)
  • [6] Persistence At 12 Months With Denosumab (Prolia®) In Postmenopausal Women With Osteoporosis: Interim Results From a Prospective Observational Study
    Silverman, Stuart L.
    Siris, Ethel
    Kendler, David L.
    Belazi, Dea
    Brown, Jacques P.
    Gold, Deborah T.
    Lewiecki, E. Michael
    Papaioannou, Alexandra
    Simonelli, Christine
    Ferreira, Irene
    Dakin, Paula
    Siddhanti, Suresh
    Stolshek, Bradley
    Recknor, Christopher
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S523 - S523
  • [7] BASELINE CHARACTERISTICS OF A PROSPECTIVE OBSERVATIONAL STUDY IN CZECH REPUBLIC (CZE) AND SLOVAKIA (SVK) TO DESCRIBE MANAGEMENT OF PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO) RECEIVING DENOSUMAB (DMAB) IN ROUTINE CLINICAL PRACTICE
    Hrdy, P.
    Kasalicky, P.
    Tomkova, S.
    Feudjo-Tepie, M.
    Zhang, E.
    Kalouche-Khalil, L.
    Killinger, Z.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S219 - S220
  • [8] Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
    L. Karlsson
    J. Lundkvist
    E. Psachoulia
    M. Intorcia
    O. Ström
    Osteoporosis International, 2015, 26 : 2401 - 2411
  • [9] Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
    Karlsson, L.
    Lundkvist, J.
    Psachoulia, E.
    Intorcia, M.
    Strom, O.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (10) : 2401 - 2411
  • [10] Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis
    Haslbauer, Ferdinand
    Petzer, Andreas
    Safanda, Martin
    Tomova, Antoaneta
    Porubska, Miriam
    Bajory, Zoltan
    Niepel, Daniela
    Jaeger, Christine
    Bjorklof, Katja
    Kalinin, Dmitry
    Greil, Richard
    SUPPORTIVE CARE IN CANCER, 2020, 28 (04) : 1855 - 1865
12345